Tag: Gilead Sciences Inc

Drugmakers Challenge Novo Nordisk and Eli Lilly in Obesity Drug Market

June 13, 2026

Drugmakers Challenge Novo Nordisk and Eli Lilly in Obesity Drug Market

How AI is Revolutionizing Drug Development & Boosting Success Rates, Says AstraZeneca CEO

June 5, 2026

How AI is Revolutionizing Drug Development & Boosting Success Rates, Says AstraZeneca CEO

Overcoming Europe’s Fragmented Capital Markets and Regulatory Hurdles

April 11, 2026

Overcoming Europe’s Fragmented Capital Markets and Regulatory Hurdles

Trump to Impose Tariffs on Drugmakers Over U.S. Drug Prices

April 5, 2026

Trump to Impose Tariffs on Drugmakers Over U.S. Drug Prices

Web Analytics